NEBIVOLOL vs RAMIPRIL

Compare NEBIVOLOL (Nebivolol) and RAMIPRIL (Ramipril) — clinical data, side effects, and patient experiences.

NEBIVOLOL

Nebivolol, Bystolic · Other

How it works

12.1 Mechanism of Action The mechanism of action of the antihypertensive response of nebivolol has not been definitively established. Possible factors that may be involved include:...

Approved for

1 INDICATIONS AND USAGE Nebivolol is a beta-adrenergic blocking agent indicated for the treatment of hypertension

to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events

primarily strokes and myocardial infarctions.( 1.1 ) 1.1 Hypertension Nebivolol tablets are indicated for the treatment of hypertension

primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes

OralTablet

RAMIPRIL

Ramipril, Altace, Tritace · ACE Inhibitor

How it works

12.1 Mechanism of Action Ramipril and ramiprilat inhibit ACE in human subjects and animals. Angiotensin converting enzyme is a peptidyl dipeptidase that catalyzes the conversion of...

Approved for

See full prescribing information

OralTablet

Quick Comparison

NEBIVOLOLRAMIPRIL

Drug Class

Other

ACE Inhibitor

Route

Oral

Half-Life

—

FDA Approved

—

Pregnancy

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

NEBIVOLOL

Fatigue

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Drug Not Working

1-10%

Nausea

1-10%

Headache

1-10%

Dizziness

1-10%

Weakness

1-10%

RAMIPRIL

Shortness of Breath

1-10%

Fatigue

1-10%

Nausea

1-10%

Diarrhea

1-10%

Dizziness

1-10%

Drug Not Working

1-10%

Vomiting

1-10%

Headache

1-10%

FDA Warnings

NEBIVOLOL

5 WARNINGS AND PRECAUTIONS Acute exacerbation of coronary artery disease upon cessation of therapy: Do not abruptly discontinue
4 Anesthesia and Major Surgery Because beta-blocker withdrawal has been associated with an increased risk of MI and chest pain, patients already on beta-blockers should generally continue treatment throughout the perioperative period
If β-blocking therapy is withdrawn prior to major surgery, the impaired ability of the heart to respond to reflex adrenergic stimuli may augment the risks of general anesthesia and surgical procedures
5 Hypoglycemia Beta-blockers may prevent early warning signs of hypoglycemia, such as tachycardia, and increase the risk for severe or prolonged hypoglycemia at any time during treatment, especially in patients with diabetes mellitus or children and patients who are fasting (i

RAMIPRIL

WARNINGS AND PRECAUTIONS ACE inhibitor use has been associated with the following: • Angioedema, with increased risk in patients with a prior history ( 5
3 ) • Increased risk of renal impairment when combined with another blocker of the renin-angiotensin-aldosterone system ( 5
, ACE inhibitors) affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving these drugs (including ramipril) may be subject to a variety of adverse reactions, some of them serious
Angioedema Head and Neck Angioedema: Patients with a history of angioedema unrelated to ACE inhibitor therapy may be at increased risk of angioedema while receiving an ACE inhibitor

Clinical Trial Data

No head-to-head clinical studies found for NEBIVOLOL vs RAMIPRIL.

NEBIVOLOL vs RAMIPRIL: What You Should Know

Key Differences

NEBIVOLOL is a Other, while RAMIPRIL belongs to the ACE Inhibitor class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles.

Safety Considerations

NEBIVOLOL carries 4 FDA warnings. RAMIPRIL carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

Lisinopril vs RAMIPRIL→RAMIPRIL vs TRANDOLAPRIL→CAPTOPRIL AND HYDROCHLOROTHIAZIDE vs RAMIPRIL→RAMIPRIL vs TRANDOLAPRIL TABLETS→CAPTOPRIL vs RAMIPRIL→RAMIPRIL vs TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE→

Loading comparison data...

NEBIVOLOL vs RAMIPRIL

Compare NEBIVOLOL (Nebivolol) and RAMIPRIL (Ramipril) — clinical data, side effects, and patient experiences.

NEBIVOLOL

Nebivolol, Bystolic · Other

How it works

12.1 Mechanism of Action The mechanism of action of the antihypertensive response of nebivolol has not been definitively established. Possible factors that may be involved include:...

Approved for

1 INDICATIONS AND USAGE Nebivolol is a beta-adrenergic blocking agent indicated for the treatment of hypertension

to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events

primarily strokes and myocardial infarctions.( 1.1 ) 1.1 Hypertension Nebivolol tablets are indicated for the treatment of hypertension

primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes

OralTablet

RAMIPRIL

Ramipril, Altace, Tritace · ACE Inhibitor

How it works

12.1 Mechanism of Action Ramipril and ramiprilat inhibit ACE in human subjects and animals. Angiotensin converting enzyme is a peptidyl dipeptidase that catalyzes the conversion of...

Approved for

See full prescribing information

OralTablet

Quick Comparison

NEBIVOLOLRAMIPRIL

Drug Class

Other

ACE Inhibitor

Route

Oral

Half-Life

—

FDA Approved

—

Pregnancy

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

NEBIVOLOL

Fatigue

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Drug Not Working

1-10%

Nausea

1-10%

Headache

1-10%

Dizziness

1-10%

Weakness

1-10%

RAMIPRIL

Shortness of Breath

1-10%

Fatigue

1-10%

Nausea

1-10%

Diarrhea

1-10%

Dizziness

1-10%

Drug Not Working

1-10%

Vomiting

1-10%

Headache

1-10%

FDA Warnings

NEBIVOLOL

5 WARNINGS AND PRECAUTIONS Acute exacerbation of coronary artery disease upon cessation of therapy: Do not abruptly discontinue
4 Anesthesia and Major Surgery Because beta-blocker withdrawal has been associated with an increased risk of MI and chest pain, patients already on beta-blockers should generally continue treatment throughout the perioperative period
If β-blocking therapy is withdrawn prior to major surgery, the impaired ability of the heart to respond to reflex adrenergic stimuli may augment the risks of general anesthesia and surgical procedures
5 Hypoglycemia Beta-blockers may prevent early warning signs of hypoglycemia, such as tachycardia, and increase the risk for severe or prolonged hypoglycemia at any time during treatment, especially in patients with diabetes mellitus or children and patients who are fasting (i

RAMIPRIL

WARNINGS AND PRECAUTIONS ACE inhibitor use has been associated with the following: • Angioedema, with increased risk in patients with a prior history ( 5
3 ) • Increased risk of renal impairment when combined with another blocker of the renin-angiotensin-aldosterone system ( 5
, ACE inhibitors) affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving these drugs (including ramipril) may be subject to a variety of adverse reactions, some of them serious
Angioedema Head and Neck Angioedema: Patients with a history of angioedema unrelated to ACE inhibitor therapy may be at increased risk of angioedema while receiving an ACE inhibitor

Clinical Trial Data

No head-to-head clinical studies found for NEBIVOLOL vs RAMIPRIL.

NEBIVOLOL vs RAMIPRIL: What You Should Know

Key Differences

NEBIVOLOL is a Other, while RAMIPRIL belongs to the ACE Inhibitor class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles.

Safety Considerations

NEBIVOLOL carries 4 FDA warnings. RAMIPRIL carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.